CN101247811B - 作为抗菌剂的喹啉衍生物 - Google Patents

作为抗菌剂的喹啉衍生物 Download PDF

Info

Publication number
CN101247811B
CN101247811B CN2006800310552A CN200680031055A CN101247811B CN 101247811 B CN101247811 B CN 101247811B CN 2006800310552 A CN2006800310552 A CN 2006800310552A CN 200680031055 A CN200680031055 A CN 200680031055A CN 101247811 B CN101247811 B CN 101247811B
Authority
CN
China
Prior art keywords
compound
alkyl
formula
mixture
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800310552A
Other languages
English (en)
Chinese (zh)
Other versions
CN101247811A (zh
Inventor
K·J·L·M·安德里斯
A·考尔
J·E·G·基勒蒙特
D·F·A·兰科伊斯
M·M·S·莫特
I·多兰格
L·J·J·巴克克斯
L·米尔波尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101247811(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CN101247811A publication Critical patent/CN101247811A/zh
Application granted granted Critical
Publication of CN101247811B publication Critical patent/CN101247811B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN2006800310552A 2005-06-28 2006-06-26 作为抗菌剂的喹啉衍生物 Expired - Fee Related CN101247811B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105762 2005-06-28
EP05105762.8 2005-06-28
PCT/EP2006/063553 WO2007000435A1 (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Publications (2)

Publication Number Publication Date
CN101247811A CN101247811A (zh) 2008-08-20
CN101247811B true CN101247811B (zh) 2013-01-02

Family

ID=34940244

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800310552A Expired - Fee Related CN101247811B (zh) 2005-06-28 2006-06-26 作为抗菌剂的喹啉衍生物

Country Status (31)

Country Link
US (1) US8841321B2 (enExample)
EP (1) EP1898914B1 (enExample)
JP (1) JP5193858B2 (enExample)
KR (1) KR101329585B1 (enExample)
CN (1) CN101247811B (enExample)
AP (1) AP2386A (enExample)
AR (1) AR054626A1 (enExample)
AU (1) AU2006263883B2 (enExample)
BR (1) BRPI0612498A8 (enExample)
CA (1) CA2612619C (enExample)
CY (1) CY1113579T1 (enExample)
DK (1) DK1898914T3 (enExample)
EA (1) EA014423B1 (enExample)
ES (1) ES2393203T3 (enExample)
HR (1) HRP20120912T1 (enExample)
IL (1) IL188393A0 (enExample)
JO (1) JO2752B1 (enExample)
ME (1) ME01484B (enExample)
MX (1) MX2008000081A (enExample)
MY (1) MY153291A (enExample)
NO (1) NO342701B1 (enExample)
NZ (1) NZ564379A (enExample)
PA (1) PA8683801A1 (enExample)
PL (1) PL1898914T3 (enExample)
PT (1) PT1898914E (enExample)
RS (1) RS52517B (enExample)
SI (1) SI1898914T1 (enExample)
TW (1) TWI387457B (enExample)
UA (1) UA92175C2 (enExample)
WO (1) WO2007000435A1 (enExample)
ZA (1) ZA200711165B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
WO2016105619A1 (en) 2014-12-23 2016-06-30 Albemarle Corporation One-step process for the synthesis of alkylated metyrapone analogs
CN106928139B (zh) * 2017-05-08 2019-06-25 福建省微生物研究所 一种贝达喹啉杂质的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
SI1527050T1 (sl) * 2002-07-25 2010-08-31 Janssen Pharmaceutica Nv Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji
WO2005033108A1 (en) * 2003-09-22 2005-04-14 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MXPA06013888A (es) * 2004-05-28 2007-01-26 Janssen Pharmaceutica Nv Uso de derivados de quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a los farmacos.
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
KR101329587B1 (ko) 2005-06-28 2013-11-15 얀센 파마슈티카 엔.브이. 항균제로서의 퀴놀린 유도체

Also Published As

Publication number Publication date
DK1898914T3 (da) 2012-11-26
CN101247811A (zh) 2008-08-20
SI1898914T1 (sl) 2013-01-31
NO20080501L (no) 2008-02-28
HK1122730A1 (en) 2009-05-29
TWI387457B (zh) 2013-03-01
AU2006263883B2 (en) 2012-12-13
NO342701B1 (no) 2018-07-09
JO2752B1 (en) 2014-03-15
WO2007000435A1 (en) 2007-01-04
UA92175C2 (ru) 2010-10-11
CA2612619C (en) 2015-12-01
JP2008543964A (ja) 2008-12-04
PA8683801A1 (es) 2007-01-17
US20100048585A1 (en) 2010-02-25
EA200800154A1 (ru) 2008-10-30
EP1898914A1 (en) 2008-03-19
ME01484B (me) 2014-04-20
NZ564379A (en) 2010-11-26
MX2008000081A (es) 2008-03-24
CA2612619A1 (en) 2007-01-04
BRPI0612498A2 (pt) 2010-11-23
PL1898914T3 (pl) 2013-01-31
EP1898914B1 (en) 2012-08-15
CY1113579T1 (el) 2016-06-22
KR101329585B1 (ko) 2013-11-15
JP5193858B2 (ja) 2013-05-08
KR20080021156A (ko) 2008-03-06
IL188393A0 (en) 2008-08-07
TW200740437A (en) 2007-11-01
ES2393203T3 (es) 2012-12-19
HRP20120912T1 (hr) 2012-12-31
AP2386A (en) 2012-03-23
US8841321B2 (en) 2014-09-23
ZA200711165B (en) 2011-05-25
AR054626A1 (es) 2007-07-04
PT1898914E (pt) 2012-11-20
BRPI0612498A8 (pt) 2018-01-02
MY153291A (en) 2015-01-29
EA014423B1 (ru) 2010-12-30
AU2006263883A1 (en) 2007-01-04
RS52517B (sr) 2013-04-30

Similar Documents

Publication Publication Date Title
CN101277695B (zh) 作为抗菌剂的喹啉衍生物
CN101553470A (zh) 抗菌的喹啉衍生物
CN101232884B (zh) 作为抗菌剂的喹啉衍生物
JP5302680B2 (ja) 抗バクテリア剤としてのキノリン誘導体
CN101547907A (zh) 抗菌的喹啉衍生物
US20130030016A1 (en) Quinoline derivatives as antibacterial agents
CN101553471A (zh) 抗菌喹啉衍生物
CN101273016B (zh) 抗菌喹啉衍生物
CN101247811A (zh) 作为抗菌剂的喹啉衍生物
CN101252928B (zh) 作为抗菌剂的喹啉衍生物
CN101277698A (zh) 作为抗菌剂的喹啉衍生物
KR101318181B1 (ko) 항균제로서의 퀴놀린 유도체
HK1122730B (en) Quinoline derivatives as antibacterial agents
HK1120734B (en) Quinoline derivatives as antibacterial agents
HK1124233B (en) Quinoline derivatives as antibacterical agents
HK1124234B (en) Quinoline derivatives as antibacterial agents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1122730

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1122730

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130102